Annual Cash & Cash Equivalents
$23.37 M
+$4.85 M+26.18%
01 December 2023
Summary:
Reviva Pharmaceuticals Holdings annual cash & cash equivalents is currently $23.37 million, with the most recent change of +$4.85 million (+26.18%) on 01 December 2023. During the last 3 years, it has risen by +$14.61 million (+166.74%). RVPH annual cash & cash equivalents is now -21.29% below its all-time high of $29.69 million, reached on 31 December 2021.RVPH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$5.56 M
-$619.40 K-10.03%
01 September 2024
Summary:
Reviva Pharmaceuticals Holdings quarterly cash and cash equivalents is currently $5.56 million, with the most recent change of -$619.40 thousand (-10.03%) on 01 September 2024. Over the past year, it has dropped by -$17.81 million (-76.21%). RVPH quarterly cash and cash equivalents is now -84.47% below its all-time high of $35.80 million, reached on 30 June 2021.RVPH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVPH Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -76.2% |
| 3 y3 years | +166.7% | -83.4% |
| 5 y5 years | - | - |
RVPH Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.3% | +166.7% | -83.4% | +11.8% |
| 5 y | 5 years | -21.3% | >+9999.0% | -84.5% | >+9999.0% |
| alltime | all time | -21.3% | >+9999.0% | -84.5% | >+9999.0% |
Reviva Pharmaceuticals Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.56 M(-10.0%) |
| June 2024 | - | $6.18 M(-48.4%) |
| Mar 2024 | - | $11.97 M(-48.8%) |
| Dec 2023 | $23.37 M(+26.2%) | $23.37 M(+370.0%) |
| Sept 2023 | - | $4.97 M(-55.4%) |
| June 2023 | - | $11.15 M(-0.9%) |
| Mar 2023 | - | $11.26 M(-39.2%) |
| Dec 2022 | $18.52 M | $18.52 M(-20.1%) |
| Sept 2022 | - | $23.19 M(+19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $19.42 M(-17.1%) |
| Mar 2022 | - | $23.42 M(-21.1%) |
| Dec 2021 | $29.69 M(+238.9%) | $29.69 M(-11.4%) |
| Sept 2021 | - | $33.49 M(-6.5%) |
| June 2021 | - | $35.80 M(+534.3%) |
| Mar 2021 | - | $5.64 M(-35.6%) |
| Dec 2020 | $8.76 M(>+9900.0%) | $8.76 M(>+9900.0%) |
| Nov 2020 | - | $36.60 K |
| Dec 2019 | $200.00 | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly cash and cash equivalents year-on-year change?
What is Reviva Pharmaceuticals Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of RVPH is $23.37 M
What is the all time high annual cash & cash equivalents for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual cash & cash equivalents is $29.69 M
What is Reviva Pharmaceuticals Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RVPH is $5.56 M
What is the all time high quarterly cash and cash equivalents for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly cash and cash equivalents is $35.80 M
What is Reviva Pharmaceuticals Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, RVPH quarterly cash and cash equivalents has changed by -$17.81 M (-76.21%)